20.30
price up icon0.50%   0.15
 
loading
前日終値:
$20.15
開ける:
$20.01
24時間の取引高:
140.91K
Relative Volume:
0.25
時価総額:
$569.46M
収益:
$17.16M
当期純損益:
$-163.62M
株価収益率:
-3.3388
EPS:
-6.08
ネットキャッシュフロー:
$-121.61M
1週間 パフォーマンス:
+1.40%
1か月 パフォーマンス:
-22.62%
6か月 パフォーマンス:
+8.93%
1年 パフォーマンス:
-46.40%
1日の値動き範囲:
Value
$19.60
$20.41
1週間の範囲:
Value
$19.48
$20.47
52週間の値動き範囲:
Value
$12.21
$40.70

Anaptysbio Inc Stock (ANAB) Company Profile

Name
名前
Anaptysbio Inc
Name
セクター
Healthcare (1161)
Name
電話
858-362-6295
Name
住所
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Name
職員
136
Name
Twitter
@anaptysbio
Name
次回の収益日
2024-11-08
Name
最新のSEC提出書
Name
ANAB's Discussions on Twitter

ANAB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ANAB
Anaptysbio Inc
20.34 560.02M 17.16M -163.62M -121.61M -6.08
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.87 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
600.37 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
463.48 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
663.74 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.02 37.96B 3.81B -644.79M -669.77M -6.24

Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-04 アップグレード H.C. Wainwright Neutral → Buy
2025-02-04 開始されました Wolfe Research Outperform
2024-12-11 ダウングレード H.C. Wainwright Buy → Neutral
2024-12-02 ダウングレード BTIG Research Buy → Neutral
2024-07-22 開始されました H.C. Wainwright Buy
2024-07-19 アップグレード JP Morgan Neutral → Overweight
2024-04-16 開始されました Leerink Partners Outperform
2024-04-11 開始されました Wells Fargo Overweight
2024-03-12 アップグレード Wedbush Neutral → Outperform
2024-02-26 開始されました BTIG Research Buy
2024-02-21 開始されました Stifel Buy
2024-02-16 開始されました Piper Sandler Overweight
2023-05-22 アップグレード JP Morgan Underweight → Neutral
2023-05-18 開始されました TD Cowen Outperform
2023-01-06 ダウングレード Raymond James Outperform → Mkt Perform
2022-11-01 アップグレード Guggenheim Neutral → Buy
2022-09-19 再開されました H.C. Wainwright Buy
2022-09-13 ダウングレード Truist Buy → Hold
2022-09-01 開始されました Raymond James Outperform
2022-03-22 ダウングレード Guggenheim Buy → Neutral
2021-06-22 開始されました H.C. Wainwright Buy
2021-05-21 開始されました UBS Neutral
2021-03-16 アップグレード Truist Hold → Buy
2021-03-09 ダウングレード Wedbush Outperform → Neutral
2021-03-08 ダウングレード JP Morgan Overweight → Underweight
2021-02-11 アップグレード JP Morgan Underweight → Overweight
2020-10-27 アップグレード Wedbush Neutral → Outperform
2020-10-14 アップグレード Guggenheim Neutral → Buy
2019-11-08 ダウングレード JP Morgan Overweight → Underweight
2019-11-08 ダウングレード Jefferies Buy → Hold
2019-11-08 ダウングレード SunTrust Buy → Hold
2019-11-08 ダウングレード Wedbush Outperform → Neutral
2019-06-21 ダウングレード Credit Suisse Outperform → Neutral
2019-06-21 ダウングレード Stifel Buy → Hold
2018-12-20 開始されました H.C. Wainwright Buy
2018-11-21 開始されました JP Morgan Overweight
2018-07-19 開始されました Credit Suisse Outperform
2018-04-04 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2018-03-27 繰り返されました Stifel Buy
2018-03-06 繰り返されました Stifel Buy
2018-02-15 繰り返されました SunTrust Buy
2018-01-23 繰り返されました Credit Suisse Outperform
2017-11-15 開始されました SunTrust Buy
2017-11-09 開始されました Jefferies Buy
2017-10-11 繰り返されました RBC Capital Mkts Outperform
2017-09-15 開始されました RBC Capital Mkts Outperform
すべてを表示

Anaptysbio Inc (ANAB) 最新ニュース

pulisher
Aug 20, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

Trend analysis for AnaptysBio Inc. this weekSwing Trade & Expert Curated Trade Setups - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Fox Run Management L.L.C. Makes New Investment in AnaptysBio, Inc. $ANAB - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

Will AnaptysBio Inc. continue its uptrend2025 Buyback Activity & Consistent Profit Focused Trading Strategies - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Can a trend reversal in AnaptysBio Inc. lead to recoveryJuly 2025 WrapUp & AI Powered Buy/Sell Recommendations - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Earnings visualization tools for AnaptysBio Inc.Market Volume Report & Free Weekly Chart Analysis and Trade Guides - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Historical volatility pattern of AnaptysBio Inc. visualizedJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

How to manage a losing position in AnaptysBio Inc.2025 Top Decliners & Community Consensus Trade Signals - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

How to read the order book for AnaptysBio Inc.Weekly Risk Report & Weekly Stock Performance Updates - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Chart based exit strategy for AnaptysBio Inc.Day Trade & Free Weekly Watchlist of Top Performers - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Will AnaptysBio Inc. stock go up soonBreakout Watch & Risk Controlled Swing Trade Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Will breakout in AnaptysBio Inc. lead to full recoveryJuly 2025 Closing Moves & Free Community Supported Trade Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

What does recent volatility data suggest for AnaptysBio Inc.Quarterly Portfolio Report & Real-Time Volume Analysis - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

Aug 19, 2025
pulisher
Aug 18, 2025

Investigational Rosnilimab Emerges as a Novel, Differentiated Treatment Option for Rheumatoid Arthritis - Fierce Biotech

Aug 18, 2025
pulisher
Aug 17, 2025

Can machine learning forecast AnaptysBio Inc. recoveryJuly 2025 Highlights & Real-Time Market Sentiment Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

What makes AnaptysBio Inc. stock price move sharplyEarnings Trend Report & Weekly Breakout Opportunity Watchlist - mustnews.co.kr

Aug 17, 2025
pulisher
Aug 17, 2025

UBS Group Reiterates Neutral Rating for AnaptysBio (NASDAQ:ANAB) - MarketBeat

Aug 17, 2025
pulisher
Aug 17, 2025

Multi asset correlation models including AnaptysBio Inc.Layoff News & Long-Term Growth Stock Strategies - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Is AnaptysBio Inc. a good stock for dollar cost averaging2025 Price Action Summary & Smart Allocation Stock Tips - sundaytimes.kr

Aug 16, 2025
pulisher
Aug 16, 2025

Will AnaptysBio Inc. see short term momentumTrade Risk Summary & Consistent Return Strategy Ideas - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

How to recover losses in AnaptysBio Inc. stockPortfolio Return Report & Verified High Yield Trade Plans - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Federated Hermes Inc. Lowers Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

Aug 15, 2025
pulisher
Aug 15, 2025

AnaptysBio Inc. stock trend forecastTrade Volume Summary & Entry Point Strategy Guides - Newser

Aug 15, 2025
pulisher
Aug 14, 2025

Wedbush Forecasts AnaptysBio's Q3 Earnings (NASDAQ:ANAB) - MarketBeat

Aug 14, 2025
pulisher
Aug 14, 2025

Leerink Partnrs Forecasts Stronger Earnings for AnaptysBio - MarketBeat

Aug 14, 2025
pulisher
Aug 14, 2025

Is AnaptysBio Inc. a defensive stock2025 Geopolitical Influence & Daily Profit Maximizing Trade Tips - kangso.co.kr

Aug 14, 2025
pulisher
Aug 13, 2025

What technical models suggest about AnaptysBio Inc.’s comebackJuly 2025 Institutional & Momentum Based Trading Ideas - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

AnaptysBio’s (ANAB) Neutral Rating Reaffirmed at UBS Group - Defense World

Aug 13, 2025
pulisher
Aug 13, 2025

AnaptysBio (NASDAQ:ANAB) Earns Neutral Rating from UBS Group - Defense World

Aug 13, 2025
pulisher
Aug 13, 2025

AnaptysBio (NASDAQ:ANAB) Receives Neutral Rating from UBS Group - Defense World

Aug 13, 2025
pulisher
Aug 13, 2025

AnaptysBio Inc. Matches Institutional Buying FilterMarket Trend Report & Weekly High Conviction Ideas - 선데이타임즈

Aug 13, 2025
pulisher
Aug 12, 2025

UBS Maintains AnaptysBio(ANAB.US) With Hold Rating, Cuts Target Price to $20 - 富途牛牛

Aug 12, 2025
pulisher
Aug 12, 2025

UBS Adjusts Price Target on AnaptysBio to $20 From $18, Maintains Neutral Rating - MarketScreener

Aug 12, 2025
pulisher
Aug 12, 2025

What is Wedbush's Estimate for AnaptysBio Q4 Earnings? - MarketBeat

Aug 12, 2025
pulisher
Aug 12, 2025

AnaptysBio (NASDAQ:ANAB) Shares Down 9.8%Should You Sell? - MarketBeat

Aug 12, 2025
pulisher
Aug 12, 2025

UBS Raises AnaptysBio PT to $20, Maintains Neutral Rating - AInvest

Aug 12, 2025
pulisher
Aug 11, 2025

Wedbush Raises AnaptysBio (NASDAQ:ANAB) Price Target to $45.00 - MarketBeat

Aug 11, 2025
pulisher
Aug 11, 2025

AnaptysBio Receives Hold Rating from Truist Financial with $20 Target - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Zurcher Kantonalbank Zurich Cantonalbank Sells 660 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Aug 11, 2025
pulisher
Aug 11, 2025

Wedbush Weighs in on AnaptysBio’s Q3 Earnings (NASDAQ:ANAB) - Defense World

Aug 11, 2025
pulisher
Aug 11, 2025

Federated Hermes Inc. Has $154,000 Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Aug 11, 2025
pulisher
Aug 10, 2025

What moving averages say about AnaptysBio Inc.Downside Control Plan With Support Analysis - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

AnaptysBio Reports Q2 2025 Financial Results and Updates - TipRanks

Aug 10, 2025
pulisher
Aug 10, 2025

AnaptysBio (NASDAQ:ANAB) Price Target Raised to $45.00 - Defense World

Aug 10, 2025
pulisher
Aug 09, 2025

Earnings Update: AnaptysBio, Inc. (NASDAQ:ANAB) Just Reported And Analysts Are Boosting Their Estimates - 富途牛牛

Aug 09, 2025

Anaptysbio Inc (ANAB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Anaptysbio Inc (ANAB) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
RENTON HOLLINGS
Director
Aug 08 '25
Sale
19.62
10,231
200,714
4,965
$36.46
price down icon 1.13%
$86.71
price up icon 0.64%
$26.12
price up icon 1.02%
$110.44
price down icon 0.73%
$131.46
price up icon 1.58%
biotechnology ONC
$312.88
price up icon 0.74%
大文字化:     |  ボリューム (24 時間):